Cargando…

Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics

Antimicrobial resistance is mostly studied by means of phenotypic growth inhibition determinations, in combination with PCR confirmations or further characterization by means of whole genome sequencing (WGS). However, the actual proteins that cause resistance such as enzymes and a lack of porins can...

Descripción completa

Detalles Bibliográficos
Autores principales: Foudraine, Dimard E., Strepis, Nikolaos, Stingl, Christoph, ten Kate, Marian T., Verbon, Annelies, Klaassen, Corné H. W., Goessens, Wil H. F., Luider, Theo M., Dekker, Lennard J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203672/
https://www.ncbi.nlm.nih.gov/pubmed/34127720
http://dx.doi.org/10.1038/s41598-021-91905-w
_version_ 1783708218820657152
author Foudraine, Dimard E.
Strepis, Nikolaos
Stingl, Christoph
ten Kate, Marian T.
Verbon, Annelies
Klaassen, Corné H. W.
Goessens, Wil H. F.
Luider, Theo M.
Dekker, Lennard J. M.
author_facet Foudraine, Dimard E.
Strepis, Nikolaos
Stingl, Christoph
ten Kate, Marian T.
Verbon, Annelies
Klaassen, Corné H. W.
Goessens, Wil H. F.
Luider, Theo M.
Dekker, Lennard J. M.
author_sort Foudraine, Dimard E.
collection PubMed
description Antimicrobial resistance is mostly studied by means of phenotypic growth inhibition determinations, in combination with PCR confirmations or further characterization by means of whole genome sequencing (WGS). However, the actual proteins that cause resistance such as enzymes and a lack of porins cannot be detected by these methods. Improvements in liquid chromatography (LC) and mass spectrometry (MS) enabled easier and more comprehensive proteome analysis. In the current study, susceptibility testing, WGS and MS are combined into a multi-omics approach to analyze resistance against frequently used antibiotics within the beta-lactam, aminoglycoside and fluoroquinolone group in E. coli and K. pneumoniae. Our aim was to study which currently known mechanisms of resistance can be detected at the protein level using liquid chromatography–mass spectrometry (LC–MS/MS) and to assess whether these could explain beta-lactam, aminoglycoside, and fluoroquinolone resistance in the studied isolates. Furthermore, we aimed to identify significant protein to resistance correlations which have not yet been described before and to correlate the abundance of different porins in relation to resistance to different classes of antibiotics. Whole genome sequencing, high-resolution LC–MS/MS and antimicrobial susceptibility testing by broth microdilution were performed for 187 clinical E. coli and K. pneumoniae isolates. Resistance genes and proteins were identified using the Comprehensive Antibiotic Resistance Database (CARD). All proteins were annotated using the NCBI RefSeq database and Prokka. Proteins of small spectrum beta-lactamases, extended spectrum beta-lactamases, AmpC beta-lactamases, carbapenemases, and proteins of 16S ribosomal RNA methyltransferases and aminoglycoside acetyltransferases can be detected in E. coli and K. pneumoniae by LC–MS/MS. The detected mechanisms matched with the phenotype in the majority of isolates. Differences in the abundance and the primary structure of other proteins such as porins also correlated with resistance. LC–MS/MS is a different and complementary method which can be used to characterize antimicrobial resistance in detail as not only the primary resistance causing mechanisms are detected, but also secondary enhancing resistance mechanisms.
format Online
Article
Text
id pubmed-8203672
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82036722021-06-15 Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics Foudraine, Dimard E. Strepis, Nikolaos Stingl, Christoph ten Kate, Marian T. Verbon, Annelies Klaassen, Corné H. W. Goessens, Wil H. F. Luider, Theo M. Dekker, Lennard J. M. Sci Rep Article Antimicrobial resistance is mostly studied by means of phenotypic growth inhibition determinations, in combination with PCR confirmations or further characterization by means of whole genome sequencing (WGS). However, the actual proteins that cause resistance such as enzymes and a lack of porins cannot be detected by these methods. Improvements in liquid chromatography (LC) and mass spectrometry (MS) enabled easier and more comprehensive proteome analysis. In the current study, susceptibility testing, WGS and MS are combined into a multi-omics approach to analyze resistance against frequently used antibiotics within the beta-lactam, aminoglycoside and fluoroquinolone group in E. coli and K. pneumoniae. Our aim was to study which currently known mechanisms of resistance can be detected at the protein level using liquid chromatography–mass spectrometry (LC–MS/MS) and to assess whether these could explain beta-lactam, aminoglycoside, and fluoroquinolone resistance in the studied isolates. Furthermore, we aimed to identify significant protein to resistance correlations which have not yet been described before and to correlate the abundance of different porins in relation to resistance to different classes of antibiotics. Whole genome sequencing, high-resolution LC–MS/MS and antimicrobial susceptibility testing by broth microdilution were performed for 187 clinical E. coli and K. pneumoniae isolates. Resistance genes and proteins were identified using the Comprehensive Antibiotic Resistance Database (CARD). All proteins were annotated using the NCBI RefSeq database and Prokka. Proteins of small spectrum beta-lactamases, extended spectrum beta-lactamases, AmpC beta-lactamases, carbapenemases, and proteins of 16S ribosomal RNA methyltransferases and aminoglycoside acetyltransferases can be detected in E. coli and K. pneumoniae by LC–MS/MS. The detected mechanisms matched with the phenotype in the majority of isolates. Differences in the abundance and the primary structure of other proteins such as porins also correlated with resistance. LC–MS/MS is a different and complementary method which can be used to characterize antimicrobial resistance in detail as not only the primary resistance causing mechanisms are detected, but also secondary enhancing resistance mechanisms. Nature Publishing Group UK 2021-06-14 /pmc/articles/PMC8203672/ /pubmed/34127720 http://dx.doi.org/10.1038/s41598-021-91905-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Foudraine, Dimard E.
Strepis, Nikolaos
Stingl, Christoph
ten Kate, Marian T.
Verbon, Annelies
Klaassen, Corné H. W.
Goessens, Wil H. F.
Luider, Theo M.
Dekker, Lennard J. M.
Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
title Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
title_full Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
title_fullStr Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
title_full_unstemmed Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
title_short Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
title_sort exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in e. coli and k. pneumoniae using proteogenomics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203672/
https://www.ncbi.nlm.nih.gov/pubmed/34127720
http://dx.doi.org/10.1038/s41598-021-91905-w
work_keys_str_mv AT foudrainedimarde exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT strepisnikolaos exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT stinglchristoph exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT tenkatemariant exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT verbonannelies exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT klaassencornehw exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT goessenswilhf exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT luidertheom exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics
AT dekkerlennardjm exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics